Platelet function in obese children and adolescents

Hamostaseologie

Volumn 30, Issue SUPPL.1, 2010, Pages 126-132

  Lohse, J ^a   Schweigel, J ^a   Naeke, A ^a   Lee Kirsch, M A ^a   Siegert, G ^a   Bergmann, S ^a   Kuhlisch, E ^a   Suttorp, M ^a   Knofler R ^a  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

Author keywords

Children; Obesity; Platelet aggregation; Whole blood

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE;

ADOLESCENT; ADULT; ARTICLE; BLOOD; BLOOD ANALYSIS; CHILD; FEMALE; HUMAN; HYPERCHOLESTEROLEMIA; MALE; METHODOLOGY; OBESITY; PHYSIOLOGY; PRESCHOOL CHILD; REFERENCE VALUE; THROMBOCYTE; THROMBOCYTE AGGREGATION;

ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADOLESCENT; ADULT; BLOOD CHEMICAL ANALYSIS; BLOOD PLATELETS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; MALE; OBESITY; OVERWEIGHT; PLATELET AGGREGATION; REFERENCE VALUES; YOUNG ADULT;

EID: 79952109602     PISSN: 07209355     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1619093     Document Type: Article

References (43)

1. Lob-Corzilius T. Overweight and obesity in childhood - a special challenge for public health. Int J Hyg Environ Health 2007; 210: 585-589.
2. Friedland O, Nemet D, Gorodnitsky N et al. Obesity and lipid profiles in children and adolescents. J Pediatr Endocrinol Metab 2002; 15: 1011-1016.
3. Sabin MA, Shield JP. Childhood obesity. Front Horm Res 2008; 36: 85-96.
4. Weiss R, Kaufman FR. Metabolic complications of childhood obesity: identifying and mitigating the risk. Diabetes Care 2008; 31 (Suppl 2): 310-316.
5. Balagopal P, George D, Patton N et al. Lifestyle-only intervention attenuates the inflammatory state associated with obesity: a randomized controlled study in adolescents. J Pediatr 2005; 146: 342-348.
6. Haszon I, Papp F, Kovacs J et al. Platelet aggregation, blood viscosity and serum lipids in hypertensive and obese children. Eur J Pediatr 2003; 162: 385-390.
7. Woo KS, Chook P, Yu CW et al. Overweight in children is associated with arterial endothelial dysfunction and intima-media thickening. Int J Obes Relat Metab Disord 2004; 28: 852-857.
8. Cohen AT. Venous thromboembolic disease management of the nonsurgical moderate- and high-risk patient. Semin Hematol 2000; 37 (Suppl 5): 19-22.
9. Kim V, Spandorfer J. Epidemiology of venous thromboembolic disease. Emerg Med Clin North Am 2001; 19: 839-859.
10. Lowe GD. Venous and arterial thrombosis: epidemiology and risk factors at various ages. Maturitas 2004; 47: 259-263.
11. Monagle P, Adams M, Mahoney M et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47: 763-766.
12. Parasuraman S, Goldhaber SZ. Venous thromboembolism in children. Circulation 2006; 113: e12-16.
13. Ferguson MA, Gutin B, Owens S et al. Fat distribution and hemostatic measures in obese children. Am J Clin Nutr 1998; 67: 1136-1140.
14. Gallistl S, Sudi KM, Borkenstein M et al. Determinants of haemostatic risk factors for coronary heart disease in obese children and adolescents. Int J Obes Relat Metab Disord 2000; 24: 1459-1464.
15. Sudi KM, Gallistl S, Muntean W, Borkenstein MH. The relationship between plasminogen activator inhibitor-1 antigen, fat mass, and leptin in obese children and adolescents. Metabolism 2000; 49: 890-895.
16. Valle M, Gascon F, Martos R et al. Infantile obesity: a situation of atherothrombotic risk? Metabolism 2000; 49: 672-675.
17. Langer HF, Gawaz M. Platelet-vessel wall interactions in atherosclerotic disease. Thromb Haemost 2008; 99: 480-486.
18. Corsonello A, Perticone F, Malara A et al. Leptin-dependent platelet aggregation in healthy, overweight and obese subjects. Int J Obes Relat Metab Disord 2003; 27:566-573.
19. Ozata M, Avcu F, Durmus O et al. Leptin does not play a major role in platelet aggregation in obesity and leptin deficiency. Obes Res 2001; 9: 627-630.
20. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3: 135-158.
21. Holmsen H, Storm E, Day HJ. Determination of ATP and ADP in blood platelets: a modification of the firefly luciferase assay for plasma. Anal Biochem 1972; 46: 489-501.
22. Mehta P, Mehta J, Ostrowski N, Aguika E. Potentiation of platelet aggregation by chronolume. Thromb Res 1983; 32: 509-512.
23. Cacciari E, Coccheri S, Bergamaschi R et al. Hemostatic balance alterations in obese children. Acta Paediatr Scand 1982; 71: 479-484.
24. Widhalm K, Strobl W, Sinzinger H. [Effect of body weight reduction on platelet function and serum lipoproteins in obese children. Monatsschr Kinderheilkd 1981; 129: 623-626.
25. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 2005; 11: 25-35.
26. Knoefler R, Weißbach G, Kuhlisch E. Platelet function tests in childhood. Measuring aggregation and release reaction in whole blood. Semin Thromb Hemost 1998; 24: 513-521.
27. Valles J, Santos MT, Aznar J et al. Erythrocytes metabolically enhance collagen-induced platelet responsiveness via increased thromboxane production, adenosine diphosphate release, and recruitment. Blood 1991; 78: 154-162.
28. Zatta A, Prosdocimi M, Bertelé V et al. Inhibition of platelet function by polymorphonuclear leukocytes. J Lab Clin Med 1990; 16: 651-660.
29. Rauramaa R, Salonen JT, Seppanen K et al. Inhibition of platelet aggregability by moderate-intensity physical exercise: a randomized clinical trial in overweight men. Circulation 1986; 74: 939-944.
30. Tangorra A, Ferretti G, Curatola G et al. Altered properties of platelet membrane in childhood obesity. Biochem Int 1988; 17: 837-846.
31. Takaya J, Iwamoto Y, Higashino H et al. Altered intracellular calcium and phorbol 12,13-dibutyrate binding to intact platelets in young obese subjects. J Lab Clin Med 1997; 129: 245-250.
32. Lowe GD, McArdle BM, Stromberg P et al. Increased blood viscosity and fibrinolytic inhibitor in type II hyperlipoproteinaemia. Lancet 1982; 1: 472-475.
33. Corash L, Andersen J, Poindexter BJ, Schaefer EJ. Platelet function and survival in patients wit severe hypercholesterolemia. Arteriosclerosis 1981; 1: 443-448.
34. Carvalho AC, Colman RW, Lees RS. Platelet function in hyperlipoproteinemia. N Engl J Med 1974; 290: 434-438.
35. DiMinno G, Silver MJ, Cerbone AM et al. Increased fibrinogen binding to platelets from patients with familial hypercholesterolemia. Arteriosclerosis 1986; 6: 203-211.
36. Aviram M, Brook JG. Platelet activation by plasma lipoproteins. Prog Cardiovasc Dis 1987; 30: 61-72.
37. Broijersen A, Karpe F, Hamsten A et al. Alimentary lipemia enhances the membrane expression of platelet P-selectin without affecting other markers of platelet activation. Atherosclerosis 1998; 137: 107-113.
38. Gallistl S, Sudi KM, Borkenstein M et al. Correlation between cholesterol, soluble P-selectin, and D-dimer in obese children and adolescents. Blood Coagul Fibrinolysis 2000; 11: 755-760.
39. Knoefler R, Nakano T, Nakajima K et al. Remnantlike lipoproteins stimulate whole blood platelet aggregation in vitro. Thromb Res 1995; 78: 161-171.
40. Knoefler R, Urano T, Taminato T et al. Daily variation of serum lipids in relation to the circadian rhythm of platelet aggregation in healthy male person. Clin Chim Acta 1995; 239: 109-119.
41. Saniabadi AR, Umemura K, Shimoyama M et al. Aggregation of human blood platelets by remnant like lipoprotein particles of plasma chylomicrons and very low density lipoproteins. Thromb Haemost 1997; 77: 996-1001.
42. Surya II, Gorter G, Mommersteeg M, Akkerman JW. Enhancement of platelet functions by low density lipoproteins. Biochim Biophys Acta 1992; 1165: 19-26.
43. Corica F, Corsonello A, Perticone F. Effects of leptin on platelet function in obese patients. JAMA 2002; 288: 313-314.